معرفی
Professor Tülay Kuş is a distinguished faculty member at Gaziantep University Faculty of Medicine, Department of Internal Medicine, specializing in Medical Oncology. She currently holds the position of Professor after previously serving as Associate Professor since 2020. Her extensive academic and clinical career spans multiple prestigious institutions including Gaziantep University, Adıyaman University, and Dr. Ersin Arslan Education and Research Hospital.
Dr. Kuş completed her medical education at Kocaeli University Faculty of Medicine (1999-2006), followed by medical specialization at Gaziantep University Faculty of Medicine, Department of Internal Medicine (2006-2011 and 2013-2016). Her educational background reflects a strong foundation in internal medicine with specialized focus on oncology.
Her research interests span multiple areas of oncology including immunotherapy, molecular targeted therapies, breast cancer, lung cancer, gastrointestinal tumors, gynecological oncology, and radioligand therapy. Dr. Kuş has made significant contributions to the field through her extensive publication record and book chapters on cutting-edge cancer treatments.
Analysis of her 15 most recent publications (2022-2024) reveals a strong focus on precision oncology approaches, including molecular biomarkers (KRAS, STK11, KEAP1), advanced imaging techniques (FAPI PET/CT), radioligand therapies (PSMA-targeted), and critical evaluation of clinical trial methodologies. Her work demonstrates expertise across multiple cancer types with particular emphasis on breast, lung, prostate, and gastrointestinal cancers.
Scientific Awards
- 2016 Mesleki Dernekler en iyi sözel bildiri ödülü - Anatolian Medical Oncology Association
- 2015 Professional Associations Best Oral Presentation - Anatolian Medical Oncology Association
Dr. Kuş has successfully supervised multiple graduate students, with completed theses focusing on nivolumab efficacy in lung cancer, imatinib treatment in gastrointestinal stromal tumors, and genetic testing perspectives in breast and ovarian cancer. Her extensive professional development includes participation in numerous national and international oncology courses covering head and neck cancers, hematological malignancies, thoracic oncology, neuroendocrine tumors, and colorectal cancer through institutions including the University of Oxford.
She maintains active membership in the Turkish Medical Oncology Association and has contributed significantly to the field through her research, teaching, and clinical practice in medical oncology.
